文献速递慢阻肺

空间转录组学揭示慢阻肺肺气肿特异性淋巴滤泡B细胞特征

Spatial Transcriptomics Resolve an Emphysema-Specific Lymphoid Follicle B Cell Signature in Chronic Obstructive Pulmonary Disease.
PubMed 文献 · Am J Respir Crit Care Med · 2024-01-01

该研究对40例慢阻肺患者和吸烟者的肺组织进行淋巴滤泡蛋白组学和空间转录组分析,共分析115个淋巴滤泡。结果显示重度肺气肿患者淋巴滤泡中B细胞活化相关基因表达显著增加,且异常B细胞活性特征被激活(q值=2.56E-111)。结论提示淋巴滤泡内脱靶B细胞活化与自身免疫介导的肺气肿发病相关。

要点

  • 重度肺气肿患者淋巴滤泡中B细胞标记基因和滤泡组装基因表达显著升高。
  • GOLD 1-2期伴肺气肿患者淋巴滤泡显示抗原呈递、炎症和B细胞活化增殖相关基因表达增加。
  • 小叶中心型肺气肿程度与B细胞成熟和抗体产生相关基因显著关联。

核心结论

  • 淋巴滤泡内脱靶B细胞活化与自身免疫介导的肺气肿发病机制相关。

研究设计与样本

  • 研究纳入40例慢阻肺患者和吸烟者,对肺组织切片进行淋巴滤泡蛋白组学和转录组空间分析,共分析115个淋巴滤泡。
  • 肺气肿测量来自临床胸部CT扫描,样本包括活检或肺 explant 的福尔马林固定和O.C.T.固定肺组织。

主要发现

  • 在从不吸烟者中未发现淋巴滤泡。
  • 重度肺气肿受试者淋巴滤泡中滤泡组装和B细胞标记基因表达显著增加。
  • 高置信度转录分析显示淋巴滤泡中异常B细胞活性特征被激活(q值=2.56E-111)。
  • GOLD 1-2期伴肺气肿患者淋巴滤泡中抗原呈递、炎症及B细胞活化增殖相关基因表达显著增加;不伴肺气肿者呈抗炎特征。
  • 小叶中心型肺气肿范围与B细胞成熟和抗体产生相关基因显著关联,蛋白-RNA网络分析显示肺气肿淋巴滤泡具有偏向慢性B细胞活化的独特特征。

临床怎么用

  • 淋巴滤泡B细胞活化特征可能作为肺气肿相关慢阻肺的潜在生物标志物或治疗靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rationale: Within chronic obstructive pulmonary disease (COPD), emphysema is characterized by a significant yet partially understood B cell immune component. Objectives: To characterize the transcriptomic signatures from lymphoid follicles (LFs) in ever-smokers without COPD and patients with COPD with varying degrees of emphysema. Methods: Lung sections from 40 patients with COPD and ever-smokers were used for LF proteomic and transcriptomic spatial profiling. Formalin- and O.C.T.-fixed lung samples obtained from biopsies or lung explants were assessed for LF presence. Emphysema measurements were obtained from clinical chest computed tomographic scans. High-confidence transcriptional target intersection analyses were conducted to resolve emphysema-induced transcriptional networks. Measurements and Main Results: Overall, 115 LFs from ever-smokers and Global Initiative for Chronic Obstructive Lung Disease (GOLD) 1-2 and GOLD 3-4 patients were analyzed. No LFs were found in never-smokers. Differential gene expression analysis revealed significantly increased expression of LF assembly and B cell marker genes in subjects with severe emphysema. High-confidence transcriptional analysis revealed activation of an abnormal B cell activity signature in LFs (q-value = 2.56E-111). LFs from patients with GOLD 1-2 COPD with emphysema showed significantly increased expression of genes associated with antigen presentation, inflammation, and B cell activation and proliferation. LFs from patients with GOLD 1-2 COPD without emphysema showed an antiinflammatory profile. The extent of centrilobular emphysema was significantly associated with genes involved in B cell maturation and antibody production. Protein-RNA network analysis showed that LFs in emphysema have a unique signature skewed toward chronic B cell activation. Conclusions: An off-targeted B cell activation within LFs is associated with autoimmune-mediated emphysema pathogenesis.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Rojas-Quintero J, Ochsner SA, New F, et al. Spatial Transcriptomics Resolve an Emphysema-Specific Lymphoid Follicle B Cell Signature in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2024. PMID: 37934672. doi:10.1164/rccm.202303-0507LE

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。